Find policies, billing codes, payers, states, and providers
CPT 4010F: ACE Inhibitor or ARB Therapy Documentation
CPT code 4010F documents that a patient is prescribed or currently receiving an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin receptor blocker (ARB). Nationally, this measure matters because ACE inhibitors and ARBs are foundational therapies for hypertension, heart failure, and certain forms of chronic kidney disease; documenting their use supports quality reporting and clinical continuity. Key payers addressed in standard coverage and reporting contexts include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what the code represents clinically, how it is used in outpatient medication-management workflows, and where it typically appears in the service line. The publication covers payer coverage considerations, common submission practices, and related administrative elements such as usual service settings. Data not available in the input for specific modifiers, associated taxonomies, ICD-10 pairings, or related billing codes is noted as unavailable in the input. The focus is national guidance on documentation and coding for ACE inhibitor/ARB therapy rather than state-specific policy.
Customize your policy alerts
Sign up for cpt 4010F policy alerts
Get alerted when payer policies referencing 4010F are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 4010F indicates that a provider prescribes, or the patient is currently receiving, therapy with an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin receptor blocker (ARB). This code is reported to document use of these antihypertensive and renoprotective medications as part of clinical management.
-
Service type: Medication management / prescription documentation
-
Typical site of service: Outpatient clinic or office-based care, including primary care and specialty follow-up visits